HLA class II alleles associations of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.

Abstract:

:The objective of this study was to determine the HLA class II associations of the anticardiolipin (aCL) and anti-beta2GPI (abeta2GPI) antibodies in a large series of European patients with systemic lupus erythematosus (SLE). A cohort of 577 European SLE patients was enrolled. aCL and abeta2GPI were measured by ELISA methods. Molecular typing of HLA-DRB1, DRB3, DRB4, DRB5, DQA1 and DQB1 loci was performed by the polymerase chain reaction-sequence specific oligonucleotide probes (PCR-SSOP) method. aCL of IgG, IgM and IgA isotypes were detected in 22.8%, 14% and 13.9% of patients, respectively. IgG and IgM abeta2GPI were detected in 20% of patients. aCL showed positive association with HLA DRB1*04, DRB1*0402, DRB1*0403, DRB1*07, DRB3*0301, DQA1*0201, DQA1*0301, DQB1*0302, and negative association with DQA1*0501, DRB3*0202. abeta2GPI showed positive association with DRB1*0402, DRB1*0403, DQB1*0302. DRB1*0402 carried the highest relative risk for the presence of both aCL (RR=8. 1) and abeta2GPI (RR=4.6). Our results confirm the already described associations of aCL with HLA DR4 and DR7, but also demonstrate that, among the alleles at the DRB1*04 locus, the *0402 was most represented both in aCL and in abeta2GPI positive patients. In addition, HLA class II associations of abeta2GPI are for the first time extensively examined in a large cohort of European SLE patients.

journal_name

Lupus

journal_title

Lupus

authors

Galeazzi M,Sebastiani GD,Tincani A,Piette JC,Allegri F,Morozzi G,Bellisai F,Scorza R,Ferrara GB,Carcassi C,Font J,Passiu G,Smolen J,Papasteriades C,Houssiau F,Nebro AF,Ramon Garrido ED,Jedryka-Goral A,Marcolongo R

doi

10.1177/096120330000900109

subject

Has Abstract

pub_date

2000-01-01 00:00:00

pages

47-55

issue

1

eissn

0961-2033

issn

1477-0962

journal_volume

9

pub_type

临床试验,杂志文章,多中心研究

相关文献

LUPUS文献大全
  • Antiphospholipid syndrome in northwest Italy (APS Piedmont Cohort): demographic features, risk factors, clinical and laboratory profile.

    abstract::We report the experience from the Antiphospholipid Antibodies (aPL) Regional Consortium in northwest Italy, meant to support clinical research and foster collaboration among health professionals regarding the diagnosis and management of antiphospholipid syndrome (APS) patients. This cohort-study (APS Piedmont Cohort) ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312446974

    authors: Bertero MT,Bazzan M,Carignola R,Montaruli B,Silvestro E,Sciascia S,Vaccarino A,Baldovino S,Roccatello D,Antiphospholipid Piedmont Consortium.

    更新日期:2012-06-01 00:00:00

  • Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus.

    abstract::Tumor necrosis factor alpha (TNF alpha) and interleukin-6 (IL-6) play a main role in inducing acute phase protein production by hepatocytes. This study describes the serum levels of TNF alpha and IL-6 in relation to serum levels of C-reactive protein (CRP) and alpha 1-acid glycoprotein (alpha 1AG) in three systemic lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200605

    authors: Meijer C,Huysen V,Smeenk RT,Swaak AJ

    更新日期:1993-12-01 00:00:00

  • Osteoporosis: gender differences and similarities.

    abstract::Although osteoporosis has traditionally been considered a disease of women, men also incur substantial bone loss with aging, and elderly men have age-specific hip fracture incidence rates and vertebral fracture prevalence rates that are at least half those in women. Early postmenopausal bone loss (which results in the...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339900800513

    authors: Khosla S,Melton LJ 3rd,Riggs BL

    更新日期:1999-01-01 00:00:00

  • Cognitive dysfunction in SLE: development of a screening tool.

    abstract:BACKGROUND:Cognitive dysfunction (CD) is among the most common neuropsychiatric manifestations of systemic lupus erythematosus (SLE). There are two methods which have been used to detect CD in patients with SLE: traditional neuropsychological tests (NPT) and the Automated Neuropsychological Assessment Metrics (ANAM). B...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203311405374

    authors: Adhikari T,Piatti A,Luggen M

    更新日期:2011-10-01 00:00:00

  • Lupus nephritis in Latin American patients: 10-year results from a single medical center in Argentina.

    abstract:INTRODUCTION:Several studies have shown that Hispanic patients generally experience a worse renal prognosis than non-Hispanic white patients with lupus. To date, there is no report on American College of Rheumatology (ACR) renal response criteria (ACR-RRC) in patients from Latin America. OBJECTIVE:To evaluate treatmen...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315600537

    authors: Vinicki JP,Paniego FM,De Rosa G,Dubinsky D,Laborde HA,Marini A,Nasswetter G

    更新日期:2016-02-01 00:00:00

  • Coxiella burnetii infection (Q fever) mimicking systemic lupus erythematosus: two cases.

    abstract::Q fever has extremely polymorphic features, and has been reported to be associated with positivity of several autoimmune antibodies. We report two cases of atypical Q fever with a clinical presentation highly suggestive of an inflammatory systemic disease with positivity of autoimmune antibodies, mimicking systemic lu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317747721

    authors: Durupt S,Puget M,Lega JC,Durieu I,Reynaud Q

    更新日期:2017-01-01 00:00:00

  • Infections in outpatients with systemic lupus erythematosus: a prospective study.

    abstract::The objective of this study was to assess the incidence and risk factors of infections in 200 SLE outpatients. All outpatients with active or inactive SLE without infections in the previous month were included. They were assessed every 3 months. Major infections were those requiring hospitalization and parental antibi...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120301678416088

    authors: Zonana-Nacach A,Camargo-Coronel A,Yañez P,Sánchez L,Jimenez-Balderas FJ,Fraga A

    更新日期:2001-01-01 00:00:00

  • Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand.

    abstract::Background The prevalence and variation by ethnicity of cutaneous lupus in New Zealand is not known. Therefore, a cross-sectional study to determine the prevalence and variation by ethnicity of cutaneous lupus in the ethnically diverse community of South Auckland, New Zealand, was undertaken. Methods Multiple sources ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316651745

    authors: Jarrett P,Thornley S,Scragg R

    更新日期:2016-11-01 00:00:00

  • Using the GRADE system in diagnostic strategy: the case of antiphospholipid syndrome.

    abstract::Diagnostic strategy studies commonly focus on the accuracy of tests in diagnosing, and grading this body of evidence is a challenge in itself because (1) standard tools for grading evidence were designed for questions about treatment rather than diagnostic testing; and (2) the clinical usefulness of a diagnostic strat...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314543922

    authors: Mendes de Abreu M,Levy RA,Wahl D

    更新日期:2014-10-01 00:00:00

  • Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients.

    abstract::Proteinuria is the hallmark of clinical manifestation of disease activity in lupus nephritis (LN) patients, which arises from direct or indirect podocyte injury. This study is to explore the relationship between intrarenal T cell infiltration and podocyte injury in lupus nephritis (LN), and to understand the potential...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316646861

    authors: Ma R,Jiang W,Li Z,Sun Y,Wei Z

    更新日期:2016-12-01 00:00:00

  • Wegener's granulomatosis: disease course, assessment of activity and extent and treatment.

    abstract::Wegener's granulomatosis (WG) belongs to the group of necrotizing primary systemic vasculitides of unknown etiology, that are associated with anti-neutrophil cytoplasmic antibodies. The pathological hallmark of WG is the coexistence of vasculitis and granuloma. Due to more sensitive diagnostic instruments, especially ...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120398678920118

    authors: de Groot K,Gross WL

    更新日期:1998-01-01 00:00:00

  • Vitamin D insufficiency in a large female SLE cohort.

    abstract::The objective of this study was to determine the vitamin D status and its relationship with disease and therapy features and with bone mineral density in women with systemic lupus erythematosus. Non-pregnant systemic lupus erythematosus women with dual-energy X-ray absorptiometry and vitamin D measurements performed b...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309345775

    authors: Toloza SM,Cole DE,Gladman DD,Ibañez D,Urowitz MB

    更新日期:2010-01-01 00:00:00

  • Clinical management of Lupus patients during the COVID-19 pandemic.

    abstract::Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the virus causing Coronavirus disease 2019 (COVID-19), has had a huge impact on health services with a high mortality associated with complications including pneumonia and acute respiratory distress syndrome. Historical evidence suggests that Lupus patients h...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203320961848

    authors: Mason A,Rose E,Edwards CJ

    更新日期:2020-11-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Lupus erythematosus tumidus in systemic lupus erythematosus: novel association and possible role of early treatment in prevention of discoid lupus erythematosus.

    abstract::Skin involvement in systemic lupus erythematosus (SLE) occurs in varied forms. Lupus erythematosus tumidus (LET) is not known to occur with SLE. In our patient presented below, LET occurred in a patient with SLE. Some of the lesions progressed to scarring discoid lesions, while others responded very well to hydoxychlo...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu473cr

    authors: Jolly M,Laumann AE,Shea CR,Utset TO

    更新日期:2004-01-01 00:00:00

  • Complementemia in pregnancies with antiphospholipid syndrome.

    abstract::Prognosis of pregnancies in women with antiphospholipid syndrome has dramatically improved over the past two decades using conventional treatment with low molecular weight heparin and low-dose aspirin. However, despite this regimen, 10-15% of antiphospholipid syndrome patients experience pregnancy losses. Several stud...

    journal_title:Lupus

    pub_type: 社论

    doi:10.1177/0961203319882507

    authors: Tabacco S,Giannini A,Garufi C,Botta A,Salvi S,Del Sordo G,Benedetti Panici P,Lanzone A,De Carolis S

    更新日期:2019-11-01 00:00:00

  • The lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder index.

    abstract::Objective The lupus impact tracker (LIT) is a 10-item patient reported outcome tool to measure the impact of systemic lupus erythematosus or its treatment on patients' daily lives. Herein, we describe the responsiveness of the LIT and LupusQoL to changes in disease activity, using the systemic lupus erythematosus resp...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203316667494

    authors: Devilliers H,Bonithon-Kopp C,Jolly M

    更新日期:2017-04-01 00:00:00

  • Evaluation of polymorphic variants in apoptotic genes and their role in susceptibility and clinical progression to systemic lupus erythematosus.

    abstract::Background Systemic lupus erythematosus (SLE) is an autoimmune disease marked by the disruption of the immune homeostasis. Patients exhibit a wide range of clinical manifestations, and environmental and genetic factors are involved in SLE pathogenesis. Evidence suggests that abnormalities in the cellular and molecular...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316678671

    authors: Glesse N,Vianna P,Paim LMG,Matte MCC,Aguiar AKK,Palhano PL,Monticielo OA,Brenol CV,Xavier RM,Chies JAB

    更新日期:2017-06-01 00:00:00

  • Update on therapy--thalidomide in the treatment of lupus.

    abstract::Thalidomide has been shown to be an effective treatment for cutaneous forms of lupus erythematous refractory to other therapies. Thalidomide has very serious side effects, including teratogenicity and neuropathy, which limit its clinical use in lupus to such severe refractory cases. Efficacy has been confirmed in seve...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1191/096120301677213822

    authors: Karim MY,Ruiz-Irastorza G,Khamashta MA,Hughes GR

    更新日期:2001-01-01 00:00:00

  • Preventing the development of SLE: identifying risk factors and proposing pathways for clinical care.

    abstract::Although challenging, developing evidence-based approaches to an early and accurate diagnosis of systemic lupus erythematosus is a key approach to preventing disease and lupus-associated morbidity and mortality. Advances in our understanding of preclinical and incomplete lupus erythematosus have enabled the identifica...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203316640367

    authors: Choi MY,Barber MR,Barber CE,Clarke AE,Fritzler MJ

    更新日期:2016-07-01 00:00:00

  • Visceral leishmaniasis complicating a connective tissue disease: three case reports from Italy.

    abstract::We report the occurrence of visceral leishmaniasis in three patients coming from the northern part of Italy treated with immunosuppressive drugs for different rheumatic conditions. This paper highlights the importance of adequate work-up in those patients presenting with serious clinical manifestations that can compli...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu518oa

    authors: Castellino G,Govoni M,Lo Monaco A,Montecucco C,Colombo F,Trotta F

    更新日期:2004-01-01 00:00:00

  • Antiphospholipid antibodies in an in vivo thrombosis model in mice.

    abstract::The mouse model described in this study offers a unique method of determining the characteristics and mechanism(s) of action of aCL antibodies in thrombosis in vivo. In addition, this animal model enables the study of the kinetics of formation and dissolution of thrombus, as well as clot area, to be studied in a dynam...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339400300408

    authors: Pierangeli SS,Harris EN

    更新日期:1994-08-01 00:00:00

  • Neurometabolic changes in normal white matter may predict appearance of hyperintense lesions in systemic lupus erythematosus.

    abstract::To determine if neurometabolic changes in the white matter (WM) of systemic lupus erythematosus (SLE) patients may predict the appearance of small hyperintense lesions on T2-weighted magnetic resonance imaging (MRI) inside the magnetic resonance spectroscopy (MRS) region of interest (ROI). We included 30 SLE patients ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203307084723

    authors: Appenzeller S,Li LM,Costallat LT,Cendes F

    更新日期:2007-01-01 00:00:00

  • Severe valvular heart disease in a patient with primary antiphospholipid syndrome.

    abstract::Valvular replacement was performed in a patient with primary antiphospholipid syndrome and severe mitral insufficiency. The valvular tissue presented thrombotic phenomena and fibrosis with minimum inflammatory component. ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:

    authors: Alvarez-Blanco A,Egurbide-Arberas MV,Aguirre-Errasti C

    更新日期:1994-10-01 00:00:00

  • Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE.

    abstract::In examining reasons for premature atherosclerosis in systemic lupus erythematosus (SLE), we previously reported low levels of the cholesterol transport protein apolipoprotein A1 (apoA1) in these patients, and specific antibodies to purified apoA1 were identified in the sera of 5 out of 30 lupus patients. The current ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120398678920262

    authors: Dinu AR,Merrill JT,Shen C,Antonov IV,Myones BL,Lahita RG

    更新日期:1998-01-01 00:00:00

  • Bilateral choroidopathy in systemic lupus erythematosus.

    abstract::We report a case of bilateral choroidopathy in a 35-year-old woman with systemic lupus erythematosus (SLE) diagnosed 3 years previously, and treated with hydroxychloroquine and steroids that ceased 6 months before ocular signs. She complained about rapid bilateral blurred vision with a severe loss of visual acuity. Fl...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203311398510

    authors: Edouard S,Douat J,Sailler L,Arlet P,Astudillo L

    更新日期:2011-10-01 00:00:00

  • Decreased diffusion capacity on lung function testing in asymptomatic patients with systemic lupus erythematosus does not predict future lung disease.

    abstract:BACKGROUND:In a previous study performed 9 ± 3.6 years ago, 74 asymptomatic patients with systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS) underwent lung function testing. A significantly low diffusion capacity (DLCO) ranging from 45% to 70% was recorded in 28 of the 74 (37.8%) patients who wer...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314566633

    authors: Elalouf O,Fireman E,Levartovsky D,Kaufman I,Rogovski O,Elkayam O,Caspi D,Paran D

    更新日期:2015-08-01 00:00:00

  • Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.

    abstract::We conducted an open-labeled, prospective study to determine the efficacy and safety of tacrolimus as an alternative therapeutic option for those patients with refractory lupus nephritis. The study population comprised one male and eight female patients with diffuse proliferative lupus nephritis. All patients had fail...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章

    doi:10.1177/0961203310366573

    authors: Lee T,Oh KH,Joo KW,Kim YS,Ahn C,Han JS,Kim S,Chin HJ

    更新日期:2010-07-01 00:00:00

  • Autoimmunity, infertility and assisted reproductive technologies.

    abstract::Despite strongly held opinions, a trustworthy scientific basis for most statements about autoimmunity, autoimmune diseases and assisted reproductive technologies (ART) does not exist. It is not likely that autoimmunity causes infertility, nor that patients with autoimmune diseases are unusually infertile. When careful...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu2000oa

    authors: Lockshin MD

    更新日期:2004-01-01 00:00:00

  • Mannose-binding lectin serum levels in patients with systemic lupus erythematosus: association with thrombocytopaenia and seizure.

    abstract::The complement system contributes to the pathogenesis of systemic lupus erythematosus (SLE). Mannose-binding lectin (MBL) is a key molecule of the lectin pathway of complement and seems to be related to the clinical manifestations of this disease. We evaluated the serum levels of MBL and its relationship with disease ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203317722846

    authors: Cieslinski JZ,Skare TL,Nisihara R,De Messias-Reason IJ,Utiyama SRR

    更新日期:2018-03-01 00:00:00